These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4539045)

  • 1. Effects of background adaptation, length of exposure time and hypophysectomy on the quantity of melanophore stimulating substances in the hypothalamo hypophyseal complex of Rana pipiens.
    Preslock JP; Bercu BB; Brinkley HJ
    Gen Comp Endocrinol; 1972 Oct; 19(2):313-9. PubMed ID: 4539045
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanophore and adrenocortical stimulating activities of substances from the pars intermedia, pars distalis, hypothalamus and cerebral cortex of the frog, Rana pipiens.
    Preslock JP; Brinkley HJ
    Life Sci II; 1970 Dec; 9(23):1369-80. PubMed ID: 4321773
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypothalamic and cerebral cortical inhibitors of a melanocyte-stimulating substance secreted by the pars distalis of the frog pituitary gland.
    Bercu BB; Brinkley HJ
    Experientia; 1969 Aug; 25(8):879-80. PubMed ID: 4900011
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone prevents dark-background adaptation in amphibians.
    Mennin SP; Saland LC
    Neuroendocrinology; 1980 Dec; 31(6):385-9. PubMed ID: 6969864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine structure of the secretory activity of the pars intermedia of Rana pipiens.
    Perryman EK
    Gen Comp Endocrinol; 1974 May; 23(1):94-110. PubMed ID: 4545363
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of DDT upon pituitary melanocyte-stimulating hormone (MSH) activity in the anuran tadpole.
    Peaslee MH
    Gen Comp Endocrinol; 1970 Jun; 14(3):594-5. PubMed ID: 5423006
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothalamic and cerebral cortical inhibition of melanocyte-stimulating hormone secretion in the frog, Rana pipiens.
    Bercu BB; Brinkley HJ
    Endocrinology; 1967 Mar; 80(3):399-403. PubMed ID: 6020211
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.
    Hruby VJ; Smith CW; Bower A; Hadley ME
    Science; 1972 Jun; 176(4041):1331-2. PubMed ID: 4624585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical quantification of melanophore stimulating substances using polyacrylamide gel disc electrophoresis.
    Preslock JP; Brinkley HJ
    Life Sci; 1970 Feb; 9(4):215-28. PubMed ID: 5435309
    [No Abstract]   [Full Text] [Related]  

  • 10. A relationship between adrenergic blockage and the secretory process in cells of the pars intermedia of the frog Rana pipiens.
    Olsson R; Gorbman A
    Gen Comp Endocrinol; 1973 Aug; 21(1):138-47. PubMed ID: 4541986
    [No Abstract]   [Full Text] [Related]  

  • 11. MSH activity in pituitaries of rats treated with hypothalamic extracts.
    Kastin AJ; Schally AV
    Gen Comp Endocrinol; 1966 Dec; 7(3):452-6. PubMed ID: 5962647
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone in the hypothalamus of the rat.
    Bassiri RM; Utiger RD
    Endocrinology; 1974 Jan; 94(1):188-97. PubMed ID: 4202988
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of hypothalamic lesions on pituitary melanocyte-stimulating hormone.
    Taleisnik S; De Olmos J; Orías R; Tomatis ME
    J Endocrinol; 1967 Dec; 39(4):485-92. PubMed ID: 4864593
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of acute and chronic administration of DDT upon pituitary melanocyte-stimulating hormone (MSH) activity.
    Peaslee MH; Goldman M; Milburn SE
    Comp Gen Pharmacol; 1972 Jun; 3(10):191-4. PubMed ID: 4542435
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence against mass action direct feedback control of melanophore-stimulating hormone (MSH) release.
    Huntington T; Hadley ME
    Endocrinology; 1974 Aug; 95(2):472-9. PubMed ID: 4546804
    [No Abstract]   [Full Text] [Related]  

  • 16. Ionic requirements for melanophore-stimulating hormone (MSH) release.
    Bower A; Hadley ME
    Gen Comp Endocrinol; 1972 Aug; 19(1):147-58. PubMed ID: 4625838
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic requirements for melanophore-stimulating hormone (MSH) secretion.
    Hadley ME; Bower SA
    Gen Comp Endocrinol; 1976 Feb; 28(2):118-30. PubMed ID: 1083822
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular control of melanocyte stimulating hormone secretion.
    Hadley ME; Davis MD; Morgan CM
    Front Horm Res; 1977; 4():94-104. PubMed ID: 26618
    [No Abstract]   [Full Text] [Related]  

  • 19. Biogenic amines and control of melanophore stimulating hormone release.
    Bower A; Hadley ME; Hruby VJ
    Science; 1974 Apr; 184(4132):70-2. PubMed ID: 4544474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous electrical potentials and pituitary hormone (MSH) secretion.
    Davis MD; Hadley ME
    Nature; 1976 Jun; 261(5559):422-3. PubMed ID: 1084481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.